133 related articles for article (PubMed ID: 33642505)
1. [Is Neuron-Vascular Communication Disturbed in the Delayed Prenatal Brain Development of a Mouse Model of Down Syndrome?].
Ishihara K
Yakugaku Zasshi; 2021; 141(3):369-373. PubMed ID: 33642505
[TBL] [Abstract][Full Text] [Related]
2. Perturbation of the immune cells and prenatal neurogenesis by the triplication of the Erg gene in mouse models of Down syndrome.
Ishihara K; Shimizu R; Takata K; Kawashita E; Amano K; Shimohata A; Low D; Nabe T; Sago H; Alexander WS; Ginhoux F; Yamakawa K; Akiba S
Brain Pathol; 2020 Jan; 30(1):75-91. PubMed ID: 31206867
[TBL] [Abstract][Full Text] [Related]
3. Genes Associated with Disturbed Cerebral Neurogenesis in the Embryonic Brain of Mouse Models of Down Syndrome.
Ishihara K
Genes (Basel); 2021 Oct; 12(10):. PubMed ID: 34680993
[TBL] [Abstract][Full Text] [Related]
4. Enlarged brain ventricles and impaired neurogenesis in the Ts1Cje and Ts2Cje mouse models of Down syndrome.
Ishihara K; Amano K; Takaki E; Shimohata A; Sago H; Epstein CJ; Yamakawa K
Cereb Cortex; 2010 May; 20(5):1131-43. PubMed ID: 19710359
[TBL] [Abstract][Full Text] [Related]
5. Lifespan analysis of brain development, gene expression and behavioral phenotypes in the Ts1Cje, Ts65Dn and Dp(16)1/Yey mouse models of Down syndrome.
Aziz NM; Guedj F; Pennings JLA; Olmos-Serrano JL; Siegel A; Haydar TF; Bianchi DW
Dis Model Mech; 2018 Jun; 11(6):. PubMed ID: 29716957
[TBL] [Abstract][Full Text] [Related]
6. [Molecular Mechanism Underlying Abnormal Differentiation of Neural Progenitor Cells in the Developing Down Syndrome Brain].
Kurabayashi N; Sanada K
Yakugaku Zasshi; 2017; 137(7):795-800. PubMed ID: 28674289
[TBL] [Abstract][Full Text] [Related]
7. Disruption of neurogenesis and cortical development in transgenic mice misexpressing Olig2, a gene in the Down syndrome critical region.
Liu W; Zhou H; Liu L; Zhao C; Deng Y; Chen L; Wu L; Mandrycky N; McNabb CT; Peng Y; Fuchs PN; Lu J; Sheen V; Qiu M; Mao M; Lu QR
Neurobiol Dis; 2015 May; 77():106-16. PubMed ID: 25747816
[TBL] [Abstract][Full Text] [Related]
8. Gene network disruptions and neurogenesis defects in the adult Ts1Cje mouse model of Down syndrome.
Hewitt CA; Ling KH; Merson TD; Simpson KM; Ritchie ME; King SL; Pritchard MA; Smyth GK; Thomas T; Scott HS; Voss AK
PLoS One; 2010 Jul; 5(7):e11561. PubMed ID: 20661276
[TBL] [Abstract][Full Text] [Related]
9. [Identification of molecules with altered expression in the brain of mouse model for Down syndrome by comprehensive analyses].
Ishihara K
Yakugaku Zasshi; 2013; 133(9):989-94. PubMed ID: 23995807
[TBL] [Abstract][Full Text] [Related]
10. Towards the understanding of Down syndrome using mouse models.
Yamakawa K
Congenit Anom (Kyoto); 2012 Jun; 52(2):67-71. PubMed ID: 22639990
[TBL] [Abstract][Full Text] [Related]
11. Dosage-dependent over-expression of genes in the trisomic region of Ts1Cje mouse model for Down syndrome.
Amano K; Sago H; Uchikawa C; Suzuki T; Kotliarova SE; Nukina N; Epstein CJ; Yamakawa K
Hum Mol Genet; 2004 Jul; 13(13):1333-40. PubMed ID: 15138197
[TBL] [Abstract][Full Text] [Related]
12. Trisomy of Erg is required for myeloproliferation in a mouse model of Down syndrome.
Ng AP; Hyland CD; Metcalf D; Carmichael CL; Loughran SJ; Di Rago L; Kile BT; Alexander WS
Blood; 2010 May; 115(19):3966-9. PubMed ID: 20007548
[TBL] [Abstract][Full Text] [Related]
13. Absence of Prenatal Forebrain Defects in the Dp(16)1Yey/+ Mouse Model of Down Syndrome.
Goodliffe JW; Olmos-Serrano JL; Aziz NM; Pennings JL; Guedj F; Bianchi DW; Haydar TF
J Neurosci; 2016 Mar; 36(10):2926-44. PubMed ID: 26961948
[TBL] [Abstract][Full Text] [Related]
14. Engineering DYRK1A overdosage yields Down syndrome-characteristic cortical splicing aberrations.
Toiber D; Azkona G; Ben-Ari S; Torán N; Soreq H; Dierssen M
Neurobiol Dis; 2010 Oct; 40(1):348-59. PubMed ID: 20600907
[TBL] [Abstract][Full Text] [Related]
15. Human neural stem cells: a new tool for studying cortical development in Down's syndrome.
Bhattacharyya A; Svendsen CN
Genes Brain Behav; 2003 Jun; 2(3):179-86. PubMed ID: 12931791
[TBL] [Abstract][Full Text] [Related]
16. The fetal brain transcriptome and neonatal behavioral phenotype in the Ts1Cje mouse model of Down syndrome.
Guedj F; Pennings JL; Ferres MA; Graham LC; Wick HC; Miczek KA; Slonim DK; Bianchi DW
Am J Med Genet A; 2015 Sep; 167A(9):1993-2008. PubMed ID: 25975229
[TBL] [Abstract][Full Text] [Related]
17. Apigenin as a Candidate Prenatal Treatment for Trisomy 21: Effects in Human Amniocytes and the Ts1Cje Mouse Model.
Guedj F; Siegel AE; Pennings JLA; Alsebaa F; Massingham LJ; Tantravahi U; Bianchi DW
Am J Hum Genet; 2020 Nov; 107(5):911-931. PubMed ID: 33098770
[TBL] [Abstract][Full Text] [Related]
18. Early lineage priming by trisomy of Erg leads to myeloproliferation in a Down syndrome model.
Ng AP; Hu Y; Metcalf D; Hyland CD; Ierino H; Phipson B; Wu D; Baldwin TM; Kauppi M; Kiu H; Di Rago L; Hilton DJ; Smyth GK; Alexander WS
PLoS Genet; 2015 May; 11(5):e1005211. PubMed ID: 25973911
[TBL] [Abstract][Full Text] [Related]
19. Defects in embryonic neurogenesis and initial synapse formation in the forebrain of the Ts65Dn mouse model of Down syndrome.
Chakrabarti L; Galdzicki Z; Haydar TF
J Neurosci; 2007 Oct; 27(43):11483-95. PubMed ID: 17959791
[TBL] [Abstract][Full Text] [Related]
20. A flavonoid agonist of the TrkB receptor for BDNF improves hippocampal neurogenesis and hippocampus-dependent memory in the Ts65Dn mouse model of DS.
Stagni F; Giacomini A; Guidi S; Emili M; Uguagliati B; Salvalai ME; Bortolotto V; Grilli M; Rimondini R; Bartesaghi R
Exp Neurol; 2017 Dec; 298(Pt A):79-96. PubMed ID: 28882412
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
